Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

N/ACompletedNCT00185887

Stanford University110 enrolled

Overview

To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

110

Conditions

Fetal Distress

Interventions

TerbutalineDRUG

Terbutaline 250 micrograms intravenously for intrapartum fetal resuscitation. Nitroglycerine 400 micrograms intravenously for intrapartum fetal resuscitation.

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria:: * nonreassuring fetal heart rate tracing Exclusion Criteria:- maternal cardiac disease, placental abruption, intrauterine growth restriction, prior cesarean section

Locations (1)

Stanford University School of Medicine

Stanford, California, United States

Outcomes

Primary Outcomes

resolution of abnormal fetal heart tracing

Time frame: Administration of study medication to resolution of abnormal fetal heart tracing or operative delivery.

Secondary Outcomes

cesarean section rate

Time frame: Data analysis

operative vaginal delivery rate

Time frame: Data analysis

neonatal outcomes

Time frame: time of delivery to time of discharge

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.